Literature DB >> 21663557

Development of novel nucleic acid-loaded Bubble liposomes using cholesterol-conjugated siRNA.

Yoichi Negishi1, Yoko Endo-Takahashi, Kazumi Ishii, Ryo Suzuki, Yukiko Oguri, Takashi Murakami, Kazuo Maruyama, Yukihiko Aramaki.   

Abstract

Recently, we developed polyethyleneglycol (PEG)-modified liposomes (Bubble liposomes; BLs) entrapping ultrasound (US) gas and reported that the combination of BLs and US exposure was an effective tool for the delivery of siRNA directly into cells and US-exposed tissues within a short period; however, the results were obtained using a mixture of BLs and naked siRNA. With systemic injections, it is important to control the biodistribution of both BLs and siRNA. In addition, the delivery of siRNA is affected by nuclease degradation and rapid removal from the circulation after intravenous administration. In this study, we attempted to prepare novel siRNA-loaded BLs (chol-si-BLs) using cholesterol-conjugated siRNA (chol-siRNA). We demonstrated that chol-siRNA could be loaded into BLs, leading to the stability of siRNA even in the presence of an RNase. The specific gene-silencing effect was also achieved by transfection with chol-si-BLs and US. Thus, the combination of chol-si-BLs with US exposure is expected to deliver siRNA into a specific tissue via systemic injection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21663557     DOI: 10.3109/1061186X.2011.585428

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  2 in total

1.  Acoustic Cavitation-Mediated Delivery of Small Interfering Ribonucleic Acids with Phase-Shift Nano-Emulsions.

Authors:  Mark T Burgess; Tyrone M Porter
Journal:  Ultrasound Med Biol       Date:  2015-05-13       Impact factor: 2.998

2.  Stably engineered nanobubbles and ultrasound - An effective platform for enhanced macromolecular delivery to representative cells of the retina.

Authors:  Sachin S Thakur; Micheal S Ward; Amirali Popat; Nicole B Flemming; Marie-Odile Parat; Nigel L Barnett; Harendra S Parekh
Journal:  PLoS One       Date:  2017-05-25       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.